BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 11677955)

  • 1. Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma.
    Linder S; Castaños-Velez E; von Rosen A; Biberfeld P
    Hepatogastroenterology; 2001; 48(41):1321-7. PubMed ID: 11677955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Composition of extracellular matrix and distribution of cell adhesion molecules in renal cell tumors.
    Droz D; Patey N; Paraf F; Chrétien Y; Gogusev J
    Lab Invest; 1994 Nov; 71(5):710-8. PubMed ID: 7526040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic carcinomas deposit laminin-5, preferably adhere to laminin-5, and migrate on the newly deposited basement membrane.
    Tani T; Lumme A; Linnala A; Kivilaakso E; Kiviluoto T; Burgeson RE; Kangas L; Leivo I; Virtanen I
    Am J Pathol; 1997 Nov; 151(5):1289-302. PubMed ID: 9358755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
    BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
    Chaturvedi P; Singh AP; Moniaux N; Senapati S; Chakraborty S; Meza JL; Batra SK
    Mol Cancer Res; 2007 Apr; 5(4):309-20. PubMed ID: 17406026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promotion of tumor cell migration by extracellular matrix proteins in human pancreatic cancer.
    Ryschich E; Khamidjanov A; Kerkadze V; Büchler MW; Zöller M; Schmidt J
    Pancreas; 2009 Oct; 38(7):804-10. PubMed ID: 19893454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SERPINE2 (protease nexin I) promotes extracellular matrix production and local invasion of pancreatic tumors in vivo.
    Buchholz M; Biebl A; Neesse A; Wagner M; Iwamura T; Leder G; Adler G; Gress TM
    Cancer Res; 2003 Aug; 63(16):4945-51. PubMed ID: 12941819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of integrins by interleukin-1alpha, and their relationship with metastatic and invasive behavior of human pancreatic ductal adenocarcinoma cells.
    Sawai H; Takeyama H; Yamamoto M; Furuta A; Funahashi H; Okada Y; Sato M; Tanaka M; Manabe T
    J Surg Oncol; 2003 Jan; 82(1):51-6. PubMed ID: 12501168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of integrin chains in normal and neoplastic human pancreas.
    Hall PA; Coates P; Lemoine NR; Horton MA
    J Pathol; 1991 Sep; 165(1):33-41. PubMed ID: 1720170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divalent cations modulate the integrin-mediated malignant phenotype in pancreatic cancer cells.
    Grzesiak JJ; Bouvet M
    Cancer Sci; 2008 Aug; 99(8):1553-63. PubMed ID: 18754866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis.
    Capo-Chichi CD; Smith ER; Yang DH; Roland IH; Vanderveer L; Cohen C; Hamilton TC; Godwin AK; Xu XX
    Cancer; 2002 Oct; 95(8):1802-15. PubMed ID: 12365030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrolamellar carcinoma of the liver: composition of the extracellular matrix and expression of cell-matrix and cell-cell adhesion molecules.
    Scoazec JY; Flejou JF; D'Errico A; Fiorentino M; Zamparelli A; Bringuier AF; Feldmann G; Grigioni WF
    Hepatology; 1996 Nov; 24(5):1128-36. PubMed ID: 8903387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity.
    Erkan M; Kleeff J; Gorbachevski A; Reiser C; Mitkus T; Esposito I; Giese T; Büchler MW; Giese NA; Friess H
    Gastroenterology; 2007 Apr; 132(4):1447-64. PubMed ID: 17408641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
    Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
    Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components.
    Tsanou E; Ioachim E; Briasoulis E; Charchanti A; Damala K; Karavasilis V; Pavlidis N; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Dec; 23(4):641-50. PubMed ID: 15743035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of matrix metalloproteinase-2 and components of the extracellular matrix--collagen type IV and laminin expression in detection of the invasive potential of pancreatic tumors].
    Gurevich LE
    Arkh Patol; 2003; 65(5):21-5. PubMed ID: 14664143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of glial cell line-derived neurotrophic factor (GDNF) and integrins for invasion and metastasis in human pancreatic cancer cells.
    Funahashi H; Okada Y; Sawai H; Takahashi H; Matsuo Y; Takeyama H; Manabe T
    J Surg Oncol; 2005 Jul; 91(1):77-83. PubMed ID: 15999351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal interactions between human ovarian surface epithelial cells and adjacent extracellular matrix.
    Kruk PA; Uitto VJ; Firth JD; Dedhar S; Auersperg N
    Exp Cell Res; 1994 Nov; 215(1):97-108. PubMed ID: 7525326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of TGF-beta 1 protein and mRNA and the effect on the tissue remodeling in laryngeal carcinomas.
    Hagedorn H; Sauer U; Schleicher E; Nerlich A
    Anticancer Res; 1999; 19(5B):4265-72. PubMed ID: 10628385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma.
    Masaki Y; Oka M; Ogura Y; Ueno T; Nishihara K; Tangoku A; Takahashi M; Yamamoto M; Irimura T
    Hepatogastroenterology; 1999; 46(28):2240-5. PubMed ID: 10521973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.